ClinicalTrials.Veeva

Menu

Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD)

R

Ruihua Shi

Status

Unknown

Conditions

Refractory Gastroesophageal Reflux Disease

Treatments

Procedure: anti-reflux mucosectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT03259191
GI of Zhongda

Details and patient eligibility

About

Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.

Enrollment

20 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Full sufficiency in literacy
  2. Be off proton pump inhibitor, antacids and prokinetics ≥ 2 weeks
  3. Refractory gastroesophageal reflux disease

Exclusion criteria

  1. Severe heart, lung, and cerebrovascular disease
  2. Severe hematopoietic system disease
  3. Abnormal blood coagulation function
  4. Oropharyngeal abnormalities
  5. Severe spine malformation
  6. In pregnancy and lactation at present, or plan to become pregnant within 2 years
  7. Severe inflammation or huge ulcers in stomach
  8. Mental and psychological disorde

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

20 participants in 2 patient groups

completely circumferential ARMS
Other group
Treatment:
Procedure: anti-reflux mucosectomy
semi-circumferential ARMS
Other group
Treatment:
Procedure: anti-reflux mucosectomy

Trial contacts and locations

1

Loading...

Central trial contact

Ruihua Shi, MD,PhD; Jiacheng Tan, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems